1Visse R, Nagase H. Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases: Structure, Function, and Biochemistry. Circulation Research ,2003,92:827-839.
2Giannelli G, Erriquez R, Iannone F, et al. MMP-2, MMP-9, TIMP-1 and TIMP-2 levels in patients with rheumatoid arthritis and psoriatic arthritis. Clin Exp Rheumato1,2004 ,22 :335-338.
3Hulkkonen J, Pertovanra M, Antonen J, et al. Matrix metalloproteinase 9 (MMP-9) gene polymorphism and MMP-9 plasma levels in primary Sj? gren's syndrome. Rheumatology, 2004,43 : 1476 - 1479.
4Mawrin C, Brunn A, Rocken C, et al. Peripheral neuropathy in systemic lupus erythematosus:pathomorphological features and distribution pattern of matrix metalloproteinases. Acta Neuropathol (Berl) ,2003,105 :365 -372.
5Vaday GG, Hershkoviz R, Rahat MA, et al. Fibronectin-bound TNF-alpha stimulates monocyte matrix metalloproteinase-9 expression and regulates chemotaxis. J Leukoc Biol,2000,68: 737-747.
6Opdenakker G, Van den Steen PE. Gelatinase B : a tuner and amplifier of immune functions. Trends in Immunology,2001,22 : 571-579.
7Huhtala P,Tuuttila A, Chow LT, et al. Complete structure of the human gene for 92-kDa type IV collagenase. J. Biol. Chem, 1991,266 : 16485-16490.
8Faber-Elmann A, Eilat E, Zinger H, et al. A peptide based on an anti-DNA autoantibody downregulates matrix metalloproteinases in murine models of lupus. Clin Immunol,2002,105:223-232.
9Urushihara M, Kagami S, Kuhara T, et al. Glomerular distribution and gelatinolytic activity of matrix metalloproteinases in human glomerulonephritis. Nephrol Dial Transplant,2002,17:1189-1196.
10Faber-Elmann A ,Sthoeger Z,Tchemiack A,et al. Activity of matrix metalloproteinase-9 is elevated in sera of patients with systemic lupus erythematosus. Clin Exp Immunol,2002,127:393-398.
4RAFFETFO J D, KHALIL R A. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease [ J ]. Biochem Pharmacol, 2008, 75 (2) : 346-359.
5MAHAJAN N, DHAWAN V, MALIK S, et al. Implication of' oxidative stress and its correlation with activity of matrix metalloproteinases in patients with Takayasu's arteritis disease[J]. Int J Cardiol, 2010, 145(2) : 286 -288.
6RASHTAK S, PITFELKOW M R. Skin involvement in systemic autoimmune diseases[ J]. Curr Dir Autoimmun, 2008, 10 : 344-358.
7ROBSON W L, LEUNG A K, WOODMAN R C. The absence of anti-neutrophil cytoplasmic antibodies in patients with Henoch-Schonlein purpura [ J ]. Pediatr Nephrol, 1994, 8 ( 3 ) : 295-298.
8胡亚美,诸福堂.实用儿科学[M].7版.北京:人民卫生出版社,2002:1174
9Gando S,Nanzaki S,Morimoto Y,et al.Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury[J].Intensive Care Med,2000,26 (1):38-44.
10Gando S,Nanzaki S,Morimoto Y,et al.Out-of-hospital cardiac arrest increases soluble vascular endothelial adhesion molecules and neutrophil elastase associated with endothelial injury[J].Intensive Care Med,2000,26(1):38-44.
